Cardiac side-effects of trastuzumab: lessons learned from targeting cancer pathways

A recent study has found that symptomatic cardiac toxicity may be a little higher in actual practice than in reports from the clinical trial of trastuzumab, and this finding needs to be incorporated into decision making, especially for lower-risk cases.

Download full article